Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M306916200 on August 25, 2003

J. Biol. Chem., Vol. 278, Issue 45, 44489-44495, November 7, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/45/44489    most recent
M306916200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anderson, P. J.
Right arrow Articles by Bock, P. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anderson, P. J.
Right arrow Articles by Bock, P. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Role of Prothrombin Fragment 1 in the Pathway of Regulatory Exosite I Formation during Conversion of Human Prothrombin to Thrombin*

Patricia J. Anderson{ddagger} and Paul E. Bock§

From the Department of Pathology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232

Prothrombin (Pro) activation by factor Xa generates the thrombin catalytic site and exosites I and II. The role of fragment 1 (F1) in the pathway of exosite I expression during Pro activation was characterized in equilibrium binding studies using hirudin54–65 labeled with 6-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)hexanoate ([NBD]Hir54–65()) or 5-(carboxy)fluorescein ([5F]Hir54–65()). [NBD]Hir54–65() distinguished exosite I environments on Pro, prethrombin 1 (Pre 1), and prethrombin 2 (Pre 2) but bound with the same affinities as [5F]Hir54–65(). Conversion of Pro to Pre 1 caused a 7-fold increase in affinity for the peptides. Conversely, fragment 1.2 (F1.2) decreased the affinity of Pre 2 for [5F]Hir54–65() by 3-fold. This was correlated with a 16-fold increased affinity of F1.2 for Pre 2 in comparison to thrombin, demonstrating an enhancing effect of F1 on F1.2 binding. The active intermediate, meizothrombin, demonstrated a 50- to 220-fold increase in exosite affinity. Free thrombin and thrombin·F1.2 complex bound [5F]Hir54–65() with indistinguishable affinity, indicating that the effect of F1 on peptide binding was eliminated upon expression of catalytic activity and exosite I. The results demonstrate a new zymogen-specific role for F1 in modulating the affinity of ligands for exosite I. This may reflect a direct interaction between the F1 and Pre 2 domains in Pro that is lost upon folding of the zymogen activation domain. The effect of F1 on (pro)exosite I and the role of (pro)exosite I in factor Va-dependent substrate recognition suggest that the Pro activation pathway may be regulated by (pro)exosite I interactions with factor Va.


Received for publication, June 29, 2003 , and in revised form, August 11, 2003.

* This work was supported by National Institutes of Health Grant HL38779 (to P. E. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} Supported by a postdoctoral fellowship from the American Heart Association, Southeastern Consortium (SE-9820133V) and subsequently by an Institutional National Research Service Award (DK07186). Present address: Howard Hughes Medical Institute, Washington University School of Medicine, 660 S. Euclid, Box 8022, St. Louis, MO 63110.

§ To whom correspondence should be addressed: Dept. of Pathology, Vanderbilt University School of Medicine, C3321A Medical Center North, Nashville, TN 37232-2561. Tel.: 615-343-9863; Fax: 615-343-7023; E-mail: paul.bock{at}vanderbilt.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
P. Kamath and S. Krishnaswamy
Fate of Membrane-bound Reactants and Products during the Activation of Human Prothrombin by Prothrombinase
J. Biol. Chem., October 31, 2008; 283(44): 30164 - 30173.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. K. Kroh, G. Tans, G. A. F. Nicolaes, J. Rosing, and P. E. Bock
Expression of Allosteric Linkage between the Sodium Ion Binding Site and Exosite I of Thrombin during Prothrombin Activation
J. Biol. Chem., June 1, 2007; 282(22): 16095 - 16104.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. A. Bukys, P. Y. Kim, M. E. Nesheim, and M. Kalafatis
A Control Switch for Prothrombinase: CHARACTERIZATION OF A HIRUDIN-LIKE PENTAPEPTIDE FROM THE COOH TERMINUS OF FACTOR Va HEAVY CHAIN THAT REGULATES THE RATE AND PATHWAY FOR PROTHROMBIN ACTIVATION
J. Biol. Chem., December 22, 2006; 281(51): 39194 - 39204.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. A. Kretz, A. R. Stafford, J. C. Fredenburgh, and J. I. Weitz
HD1, a Thrombin-directed Aptamer, Binds Exosite 1 on Prothrombin with High Affinity and Inhibits Its Activation by Prothrombinase
J. Biol. Chem., December 8, 2006; 281(49): 37477 - 37485.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. A. Bukys, T. Orban, P. Y. Kim, D. O. Beck, M. E. Nesheim, and M. Kalafatis
The Structural Integrity of Anion Binding Exosite I of Thrombin Is Required and Sufficient for Timely Cleavage and Activation of Factor V and Factor VIII
J. Biol. Chem., July 7, 2006; 281(27): 18569 - 18580.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Toso and R. M. Camire
Role of Hirudin-like Factor Va Heavy Chain Sequences in Prothrombinase Function
J. Biol. Chem., March 31, 2006; 281(13): 8773 - 8779.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. J. Anderson, A. Nesset, and P. E. Bock
Effects of Activation Peptide Bond Cleavage and Fragment 2 Interactions on the Pathway of Exosite I Expression during Activation of Human Prethrombin 1 to Thrombin
J. Biol. Chem., November 7, 2003; 278(45): 44482 - 44488.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement